查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1597045

绿色化学市场:绿色化学的措施，绿色化学·解决方案供应商的竞争情形，新的大趋势，大型製药公司的配合措施，企业简介，主要的促进因素与阻碍因素

Green Chemistry Market: Focus on Green Chemistry Initiatives, Competitive Landscape of Green Chemistry Solution Providers, Emerging Mega Trends, Big Pharma Initiatives, Company Profiles and Key Drivers and Restraints
出版日期: | 出版商: Roots Analysis | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

製药公司在其研究和製造过程中采用了绿色化学，在 60 多个已知用例中，绿色化学市场预计将稳步发展。

绿色化学涉及尽量减少或消除有害物质的化学产品和製程的设计、开发和实施。在製药业，绿色化学对于促进环境永续性和提高化学合成效率至关重要。传统的製药生产是能源密集的，依赖不可再生资源，导致大量废弃物的处理成本高。例如，全球活性药物成分（API）的产量估计为每年 6,500 万至 1 亿公斤，产生约 100 亿公斤废弃物，加工成本约 200 亿美元。

製药业约占全球二氧化碳排放量的 17%，其中近一半来自活性药物成分及其原料的生产。随着人们对环境的日益关注，迫切需要采用更环保的製造方法。因此，製药公司正在将绿色化学原理融入其营运中，利用光化学、电化学和生物催化等多种技术。在製药工业中，生物催化是绿色化学在化学合成上的重要应用。这种方法已展现出显着的优势，包括製造时间缩短 80%、产量提高、原材料成本降低 99% 以上，以及在纯化过程中消除有机溶剂。

绿色化学为製药业带来了多种好处，包括减少对有害物质的依赖、降低成本和提高製程效率。因此，许多製药公司越来越关注绿色化学，以确保永续的未来。尤其是阿斯特捷利康、巴斯夫和辉瑞等公司的目标是到 2040 年或 2050 年实现整个供应链的净零排放。这些努力符合全球监管标准，并满足消费者对环保产品日益增长的需求。

随着企业增加对绿色化学和永续技术的投资，绿色化学市场预计将显着成长，为药物开发和製造领域更永续和负责任的未来铺平道路。

本报告提供全球绿色化学市场相关调查，提供市场概要，以及绿色化学·解决方案供应商的竞争情形，新的大趋势，大型製药公司的配合措施，企业简介等资讯。

目录

章节I:报告概要

第1章 范围和目的

第2章 调查手法

章节II:定性性的洞察

第3章 摘要整理

第4章 简介

章节III:市场概要

第5章 市场形势:製药产业的绿色化学的配合措施

第6章 市场形势:绿色化学·解决方案供应商

章节IV:企业简介和案例研究

第7章 企业简介

  • 章概要
  • Amgen
  • AstraZeneca
  • Bristol Myers Squibb
  • Codexis
  • Johnson &Johnson
  • Merck
  • Merck KGaA
  • Pfizer

第8章 案例研究:大型製药公司的配合措施

第5章 市场趋势

第9章 绿色化学市场:进行中的兆趋势概要

第10章 对市场的影响分析:促进因素，阻碍因素，机会，课题

第5章 附录

第11章 表格形式的资料

第12章 企业·团体一览

Product Code: RA100565

With more than 60 known use cases in which pharmaceutical companies have employed green chemistry in their research / manufacturing processes, the green chemistry market is anticipated to evolve at a steady pace.

Green chemistry involves the design, development and implementation of chemical products and processes that minimize or eliminate hazardous substances. In the pharmaceutical industry, green chemistry is vital for promoting environmental sustainability and improving the efficiency of chemical synthesis. Traditional drug manufacturing is energy-intensive and dependent on non-renewable resources, leading to significant waste generation and costly disposal. For example, global production of active pharmaceutical ingredients (APIs) is estimated to be 65 million to 100 million kilograms annually, generating approximately 10 billion kilograms of waste, with disposal costs around $20 billion.

The pharmaceutical industry is responsible for approximately 17% of global carbon emissions, with nearly half of this footprint stemming from the manufacturing of APIs and their raw materials. With increasing environmental concerns, there is an urgent need for industry to adopt greener production methods. Consequently, pharmaceutical companies are integrating green chemistry principles into their operations, utilizing various techniques such as photochemistry, electrochemistry, and biocatalysis. In the pharmaceutical industry, biocatalysis presents a significant application of green chemistry in chemical synthesis. This approach has demonstrated significant advantages, including reduction in manufacturing time by 80%, increase in production yield, decrease in the cost of starting materials by more than 99%, and elimination of the use of organic solvents during purification processes.

Green chemistry provides various benefits to the pharmaceutical industry, including reduced reliance on toxic substances, cost savings, and enhanced process efficiency. Thus, many pharmaceutical companies are increasingly focusing on green chemistry to ensure a sustainable future. Notably, firms such as AstraZeneca, BASF, and Pfizer are aiming for net-zero emissions across their supply chains by 2040 or 2050. These efforts align with global regulatory standards and respond to rising consumer demand for eco-friendly products.

As companies increasingly invest in green chemistry and sustainable technologies, the green chemistry market is expected to experience substantial growth, paving the way for a more sustainable and responsible future in drug development and manufacturing.

Research Coverage:

The report on green chemistry market covers the following elements:

  • A project background providing an introduction to the context of the green chemistry market report and outlining various project objectives.
  • An overview of the systematic research methodology employed to study the green chemistry industry, providing information on various assumptions, methodologies, and quality control measures used to ensure the accuracy and reliability of our findings.
  • An infographic executive summary presenting key insights gathered during our research, providing a high-level perspective on the current state of green chemistry initiatives and green chemistry solution providers.
  • A general overview of green chemistry, covering the 12 principles of green chemistry and prominent types of green chemistry methods. It also discusses various applications of green chemistry and addresses the challenges associated with its implementation.
  • A comprehensive assessment of green chemistry initiatives within the pharma industry, based on several relevant parameters, such as the type of green chemistry method involved (biocatalysis, electrochemistry, photochemistry and others), purpose of initiative (research and manufacturing), therapeutic area of drug synthesized (cardiovascular disorders, infectious diseases, metabolic disorders, neurological disorders, oncological disorders, respiratory disorders and other disorders) and impact of initiative (energy efficient processes, improvement in yield, reduction in carbon footprint, reduction in manufacturing time, reduction in metal consumption, reduction in solvent-use, reduction in waste and others). Further, the report also provides information on the green chemistry initiatives stakeholders, along with analysis on various parameters, such as year of establishment, company size (in terms of employee count) and location of headquarters (region and country).
  • An evaluation of the green chemistry solution providers, based on various relevant parameters, such as year of establishment, company size (in terms of employee count) and location of headquarters (region and country), type of solution offered (product, platform and service), type of green chemistry method involved (biocatalysis, electrochemistry and photochemistry), pharmaceutical application (research, manufacturing and other applications), and type of service offered (research, product / process development, manufacturing, scale-up and other services).
  • Elaborate profiles of key companies in the green chemistry market. Each profile includes a brief overview of the company (year of establishment, location of headquarters, number of employees, management team and business segments), information on their green chemistry initiatives, recent developments and an informed future outlook.
  • A comprehensive case study on big pharma initiatives that examine the impact of green chemistry practices on the pharmaceutical industry.
  • A detailed assessment of various ongoing megatrends in the green chemistry industry, including rising demand for sustainable drug manufacturing, technological advancements in green chemistry practices, integration of continuous flow manufacturing with green chemistry practices, convergence of AI, data science with green chemistry applications, development of sustainability metrices, and many more.
  • A detailed analysis identifying factors that influence the growth of green chemistry market. It includes insights into key drivers, potential restraints, emerging opportunities, and existing challenges in this domain.

Key Benefits of Buying this Report

  • The report provides valuable insights into key green chemistry solution providers that are shaping the market landscape and driving sustainable practices in the industry.
  • Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
  • The report provides stakeholders with an overall outlook of the green chemistry market, featuring essential information on significant market drivers, barriers, opportunities, and challenges.

Example Companies Profiled

  • Amgen
  • AstraZeneca
  • Bristol Myers Squibb
  • Codexis
  • Johnson & Johnson
  • Merck
  • Merck KGaA
  • Pfizer

TABLE OF CONTENTS

SECTION I: REPORT OVERVIEW

1. SCOPE AND OBJECTIVES

  • 1.1. Context
  • 1.2. Project Objectives

2. RESEARCH METHODOLOGY

  • 2.1. Project Methodology
  • 2.2. Robust Quality Control Framework

SECTION II: QUALITATIVE INSIGHTS

3. EXECUTIVE SUMMARY

4. INTRODUCTION

  • 4.1. An Overview of Green Chemistry
  • 4.2. 12 Principles of Green Chemistry
  • 4.3. Types of Green Chemistry Methods
  • 4.4. Applications of Green Chemistry
  • 4.5. Key Challenges in Green Chemistry Domain

SECTION III: MARKET OVERVIEW

5. MARKET LANDSCAPE: GREEN CHEMISTRY INITIATIVES IN PHARMA INDUSTRY

  • 5.1. Methodology and Key Parameters
  • 5.2. Green Chemistry Initiatives: Overall Market Landscape
    • 5.2.1. Analysis by Type of Green Chemistry Method Involved
    • 5.2.2. Analysis by Purpose of Initiative
    • 5.2.3. Analysis by Therapeutic Area of Drug Synthesized
    • 5.2.4. Analysis by Impact of Initiative
  • 5.3. Green Chemistry Initiatives Stakeholders: Overall Market Landscape
    • 5.3.1. Analysis by Year of Establishment
    • 5.3.2. Analysis by Company Size
    • 5.3.3. Analysis by Location of Headquarters

6. MARKET LANDSCAPE: GREEN CHEMISTRY SOLUTION PROVIDERS

  • 6.1. Methodology and Key Parameters
  • 6.2. Green Chemistry Solution Providers: Overall Market Landscape
    • 6.2.1. Analysis by Year of Establishment
    • 6.2.2. Analysis by Company Size
    • 6.2.3. Analysis by Location of Headquarters
    • 6.2.4. Analysis by Type of Solution Offered
    • 6.2.5. Analysis by Type of Green Chemistry Method Involved
    • 6.2.6. Analysis by Pharmaceutical Application
    • 6.2.7. Analysis by Type of Service Offered

SECTION IV: COMPANY PROFILES AND CASE STUDY

7. COMPANY PROFILES

  • 7.1. Chapter Overview
  • 7.2. Amgen
    • 7.2.1. Company Overview
    • 7.2.2. Company Mission
    • 7.2.3. Company Footprint
    • 7.2.4. Management Team
    • 7.2.5. Contact Details
    • 7.2.6. Green Chemistry Initiatives
    • 7.2.7. Recent Developments and Future Outlook
  • 7.3. AstraZeneca
    • 7.3.1. Company Overview
    • 7.3.2. Company Mission
    • 7.3.3. Company Footprint
    • 7.3.4. Management Team
    • 7.3.5. Contact Details
    • 7.3.6. Green Chemistry Initiatives
    • 7.3.7. Recent Developments and Future Outlook
  • 7.4. Bristol Myers Squibb
    • 7.4.1. Company Overview
    • 7.4.2. Company Mission
    • 7.4.3. Company Footprint
    • 7.4.4. Management Team
    • 7.4.5. Contact Details
    • 7.4.6. Green Chemistry Initiatives
    • 7.4.7. Recent Developments and Future Outlook
  • 7.5. Codexis
    • 7.5.1. Company Overview
    • 7.5.2. Company Mission
    • 7.5.3. Company Footprint
    • 7.5.4. Management Team
    • 7.5.5. Contact Details
    • 7.5.6. Green Chemistry Initiatives
    • 7.5.7. Recent Developments and Future Outlook
  • 7.6. Johnson & Johnson
    • 7.6.1. Company Overview
    • 7.6.2. Company Mission
    • 7.6.3. Company Footprint
    • 7.6.4. Management Team
    • 7.6.5. Contact Details
    • 7.6.6. Green Chemistry Initiatives
  • 7.7. Merck
    • 7.7.1. Company Overview
    • 7.7.2. Company Mission
    • 7.7.3. Company Footprint
    • 7.7.4. Management Team
    • 7.7.5. Contact Details
    • 7.7.6. Green Chemistry Initiatives
    • 7.7.7. Recent Developments and Future Outlook
  • 7.8. Merck KGaA
    • 7.8.1. Company Overview
    • 7.8.2. Company Mission
    • 7.8.3. Company Footprint
    • 7.8.4. Management Team
    • 7.8.5. Contact Details
    • 7.8.6. Green Chemistry Initiatives
    • 7.8.7. Recent Developments and Future Outlook
  • 7.9. Pfizer
    • 7.9.1. Company Overview
    • 7.9.2. Company Mission
    • 7.9.3. Company Footprint
    • 7.9.4. Management Team
    • 7.9.5. Contact Details
    • 7.9.6. Green Chemistry Initiatives
    • 7.9.7. Recent Developments and Future Outlook

8. CASE STUDY: BIG PHARMA INITIATIVES

  • 8.1. Methodology and Key Parameters
  • 8.2. Green Chemistry: Big Pharma Initiatives
    • 8.2.1. Johnson & Johnson
    • 8.2.2. Roche
    • 8.2.3. Merck
    • 8.2.4. Pfizer
    • 8.2.5. AbbVie
    • 8.2.6. AstraZeneca
    • 8.2.7. Novartis
    • 8.2.8. Bristol Myers Squibb
    • 8.2.9. GlaxoSmithKline

SECTION V: MARKET TRENDS

9. GREEN CHEMISTRY MARKET: OVERVIEW OF ONGOING MEGA TRENDS

  • 9.1. Megatrends in the Green Chemistry Market
    • 9.1.1. Shift Towards Sustainable Drug Manufacturing
    • 9.1.2. Technological Advancements in Green Chemistry
    • 9.1.3. Integration of Continuous Flow Manufacturing in Green Chemistry
    • 9.1.4. Emphasis on Waste Valorization and Circular Chemistry
    • 9.1.5. Convergence of AI, Data Science and Green Chemistry
    • 9.1.6. Establishing Sustainability Metrices
    • 9.1.7. Increasing Adoption by Big-Pharma Companies
    • 9.1.8. Growing Regulatory Pressures

10. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

  • 10.1. Market Drivers
  • 10.2. Market Restraints
  • 10.3. Market Opportunities
  • 10.4. Market Challenges

SECTION V: APPENDIX

11. TABULATED DATA

12. LIST OF COMPANIES AND ORGANIZATIONS

List of Tables

  • Table 5.1 List of Green Chemistry Initiatives: Information on Type of Green Chemistry Method Involved, Purpose of Initiative, Impact of Initiative, Type of Product Targeted, and Therapeutic Area of Drug Synthesized
  • Table 5.2 List of Green Chemistry Initiatives Stakeholders
  • Table 6.1 List of Key Companies Offering Green Chemistry Solutions
  • Table 6.2 List of Companies Offering Green Chemistry Products and Platforms: Information on Type of Solution Offered, Type of Green Chemistry Method Involved and Pharmaceutical Application
  • Table 6.3 List of Companies Offering Green Chemistry Services: Information on Type of Type of Green Chemistry Method Involved and Type of Service Offered
  • Table 7.1 Amgen: Green Chemistry Initiatives
  • Table 7.2 AstraZeneca: Green Chemistry Initiatives
  • Table 7.3 Bristol Myers Squibb: Green Chemistry Initiatives
  • Table 7.4 Codexis: Green Chemistry Initiatives
  • Table 7.5 Johnson & Johnson: Green Chemistry Initiatives
  • Table 7.6 Merck: Green Chemistry Initiatives
  • Table 7.7 Merck KGaA: Green Chemistry Initiatives
  • Table 7.8 Pfizer: Green Chemistry Initiatives
  • Table 11.1 Green Chemistry Initiatives: Distribution by Type of Green Chemistry Method Involved
  • Table 11.2 Green Chemistry Initiatives: Distribution by Purpose of Initiative
  • Table 11.3 Green Chemistry Initiatives: Distribution by Therapeutic Area of API / Drug Synthesized
  • Table 11.4 Green Chemistry Initiatives: Distribution by Impact of Initiative
  • Table 11.5 Green Chemistry Initiatives Stakeholders: Distribution by Year of Establishment
  • Table 11.6 Green Chemistry Initiatives Stakeholders: Distribution by Company Size
  • Table 11.7 Green Chemistry Initiatives Stakeholders: Distribution by Location of Headquarters
  • Table 11.8 Green Chemistry Solution Providers: Distribution by Year of Establishment
  • Table 11.9 Green Chemistry Solution Providers: Distribution by Company Size
  • Table 11.10 Green Chemistry Solution Providers: Distribution by Location of Headquarters
  • Table 11.11 Green Chemistry Solution Providers: Distribution by Type of Solution Offered
  • Table 11.12 Green Chemistry Solution Providers: Distribution by Type of Green Chemistry Method Involved
  • Table 11.13 Green Chemistry Solution Providers: Distribution by Pharmaceutical Application
  • Table 11.14 Green Chemistry Solution Providers: Distribution by Type of Service Offered

List of Figures

  • Figure 1.1 Research Methodology: Project Methodology
  • Figure 1.2 Research Methodology: Robust Quality Control
  • Figure 3.1 Executive Summary: Market Landscape of Green Chemistry Initiatives in Pharma Industry
  • Figure 3.2 Executive Summary: Market Landscape of Green Chemistry Solution Providers
  • Figure 4.1 12 Principles of Green Chemistry
  • Figure 5.1 Green Chemistry Initiatives: Distribution by Type of Green Chemistry Method Involved
  • Figure 5.2 Green Chemistry Initiatives: Distribution by Purpose of Initiative
  • Figure 5.3 Green Chemistry Initiatives: Distribution by Therapeutic Area of API / Drug Synthesized
  • Figure 5.4 Green Chemistry Initiatives: Distribution by Impact of Initiative
  • Figure 5.5 Green Chemistry Initiatives Stakeholders: Distribution by Year of Establishment
  • Figure 5.6 Green Chemistry Initiatives Stakeholders: Distribution by Company Size
  • Figure 5.7 Green Chemistry Initiatives Stakeholders: Distribution by Location of Headquarters
  • Figure 6.1 Green Chemistry Solution Providers: Distribution by Year of Establishment
  • Figure 6.2 Green Chemistry Solution Providers: Distribution by Company Size
  • Figure 6.3 Green Chemistry Solution Providers: Distribution by Location of Headquarters
  • Figure 6.4 Green Chemistry Solution Providers: Distribution by Type of Solution Offered
  • Figure 6.5 Green Chemistry Solution Providers: Distribution by Type of Green Chemistry Method Involved
  • Figure 6.6 Green Chemistry Solution Providers: Distribution by Pharmaceutical Application
  • Figure 6.7 Green Chemistry Solution Providers: Distribution by Type of Service Offered
  • Figure 9.1 Schematic Representation of Ongoing Megatrends